Itraconazole topical - Fera Pharmaceuticals

Drug Profile

Itraconazole topical - Fera Pharmaceuticals

Alternative Names: Itraconazole suspension for topical application - Fairfield Clinical Trials/Fera Pharmaceuticals

Latest Information Update: 14 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Fairfield Clinical Trials
  • Developer Fera Pharmaceuticals
  • Class Antifungals; Azoles; Chlorobenzenes; Piperazines; Small molecules; Triazoles
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Otitis externa
  • New Molecular Entity No

Highest Development Phases

  • No development reported Otitis externa

Most Recent Events

  • 17 Apr 2016 Biomarkers information updated
  • 14 Aug 2015 No recent reports on development identified - Phase-II for Otitis externa in USA (Topical)
  • 22 Jul 2010 Phase-II clinical trials in Otitis externa in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top